1. Metabolic syndrome, autoimmunity and rheumatic diseases
   Gabriela Medina et al, 2018, Pharmacological Research CrossRef
2. Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy
   Jinfang Bao et al, 2018, Clin. Sci. CrossRef
3. Hyperuricemia and fragmented QRS
   Mehtap Tinazli et al, 2019, Gazz Med Ital - Arch Sci Med CrossRef
4. Interaction between low-density lipoprotein-cholesterolaemia, serum uric level and incident hypertension
   Arrigo F.G. Cicero et al, 2019, Journal of Hypertension CrossRef
5. Preventive Effects of Fucoidan and Fucoxanthin on Hyperuricemic Rats Induced by Potassium Oxonate.
   Yung-Tsung Chau et al, 2019, Mar Drugs CrossRef
6. Hyperuricemia and Cardiovascular Disease.
   Shuangshuang Zhang et al, 2019, Curr Pharm Des CrossRef
7. Urate hydroperoxide oxidizes endothelial cell surface protein disulfide isomerase-A1 and impairs adherence
   Marcela Franco Mineiro et al, 2019, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
8. U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients
   Ziqiong Wang et al, 2020, Upsala Journal of Medical Sciences CrossRef
9. Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
   Gerwyn Morris et al, 2020, BMC Med CrossRef
10. Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence
    Muthukumaran Jayachandran et al, 2020, Med Res Rev CrossRef
11. 27‐Hydroxycholesterol regulates human SLC22A12 gene expression through estrogen receptor action
    Masaya Matsubayashi et al, 2021, FASEB j. CrossRef
12. The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy
    Li Wen et al, 2021, Mol Cell Biochem CrossRef
13. Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
    Elisa Russo et al, 2021, JCM CrossRef
14. Plasma uric acid is related to large arterial stiffness but not to other hemodynamic variables: a study in 606 normotensive and never-medicated hypertensive subjects
    Humam Hamid et al, 2021, BMC Cardiovasc Disord CrossRef
15. Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: a subgroup analysis of the PROLOGUE study
    Yipin Zhao et al, 2021, Therapeutic Advances in Chronic Disease CrossRef
16. Hyperuricemia-induced endothelial insulin resistance: the nitric oxide connection
    Zahra Bahadoran et al, 2021, Pflugers Arch - Eur J Physiol CrossRef
17. Mesenchymal stem cells transplantation attenuates hyperuricemic nephropathy in rats
    Lan Li et al, 2021, International Immunopharmacology CrossRef
18. Total Flight Hours and Other Factors Associated with Hyperuricemia in Civilian Pilots
    Simplisius Cornelis Tisera et al, 2022, aerosp med hum perform CrossRef
19. Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?
    Giovanna Leoncini et al, 2022 CrossRef
20. A κ-OR Agonist Protects the Endothelial Function Impaired by Hyperuricemia Through Regulating the Akt/eNOS Signal Pathway
    Qin Zheng et al, 2022, Probiotics & Antimicro. Prot. CrossRef
21. Uric Acid Reacts with Peroxidasin, Decreases Collagen IV Crosslink, Impairs Human Endothelial Cell Migration and Adhesion
    Bianca Dempsey et al, 2022, Antioxidants CrossRef
22. Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?
    Asmaa Elrakaybi et al, 2022, Molecular Metabolism CrossRef
23. Febuxostat as an effective drug of choice for urate-lowering therapy for gout (case report)
    A. B. Bashkova et al, 2022, Medicinskij sovet CrossRef
24. Endothelial dysfunction: developmental mechanisms and therapeutic strategies
    Dmitry V. Shcheblykin et al, 2022, RRP CrossRef
25. Therapeutic effects of traditional Chinese medicine on gouty nephropathy: Based on NF-κB signalingpathways.
    Peng Liu et al, 2023, Biomed Pharmacother CrossRef
26. Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques
    Eleana Bolla et al, 2023, Front. Immunol. CrossRef
27. Association of hyperuricemia with cardiovascular diseases: current evidence
    Steven G. Chrysant, 2023, Hospital Practice CrossRef
28. Integrative metabolomic and network pharmacological analysis reveals potential mechanisms of Cardamine circaeoides Hook.f. & Thomson in alleviating potassium oxonate-induced asymptomatic hyperuricemia in rats
    Yingli Zhu et al, 2023, Front. Pharmacol. CrossRef
29. Insights into the relationship between serum uric acid and pulmonary hypertension (Review)
    Yu Zhou et al, 2023, Mol Med Rep CrossRef
30. Comparative Levels of Urinary Biomarkers of Renal Injury and Inflammation Among Patients With Diabetic Nephropathy With or Without Hyperuricemia
    Ryan Alex et al, 2024, J Clin Rheumatol CrossRef
31. Asymptomatic Hyperuricemia and the Kidney: Lessons from the URRAH Study
    Cecilia Barnini et al, 2025, Metabolites CrossRef
32. Gut microbiota as a new target for hyperuricemia: A perspective from natural plant products
    Ling Dong et al, 2025, Phytomedicine CrossRef